BRD2
Basic information
Region (hg38): 6:32968594-32981505
Previous symbols: [ "BRD2-IT1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 21 | ||||
missense | 32 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 6 | 2 | 8 | |||
non coding | 1 | |||||
Total | 0 | 0 | 32 | 13 | 16 |
Variants in BRD2
This is a list of pathogenic ClinVar variants found in the BRD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-32972917-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
6-32972923-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
6-32974446-G-GT | not specified | Benign (-) | ||
6-32974467-C-T | not specified | Uncertain significance (May 12, 2015) | ||
6-32974473-A-C | not specified | Uncertain significance (Aug 03, 2022) | ||
6-32974485-G-C | not specified | Uncertain significance (Jan 04, 2022) | ||
6-32974487-T-C | BRD2-related disorder | Benign (Dec 31, 2019) | ||
6-32974500-G-A | Benign (Dec 31, 2019) | |||
6-32974525-G-A | BRD2-related disorder | Benign (Oct 17, 2019) | ||
6-32974575-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
6-32974609-C-A | Benign (Dec 31, 2019) | |||
6-32974633-C-T | BRD2-related disorder | Benign (Dec 31, 2019) | ||
6-32974654-A-G | Likely benign (Oct 23, 2018) | |||
6-32974717-C-T | BRD2-related disorder | Likely benign (Jun 22, 2018) | ||
6-32975374-T-C | BRD2-related disorder | Benign (Oct 17, 2019) | ||
6-32975411-A-G | not specified | Uncertain significance (May 14, 2024) | ||
6-32975448-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
6-32975452-T-C | Benign (Dec 31, 2019) | |||
6-32975509-C-T | BRD2-related disorder | Likely benign (Feb 28, 2019) | ||
6-32976026-C-T | BRD2-related disorder | Likely benign (Mar 08, 2019) | ||
6-32976031-C-G | not specified | Uncertain significance (Apr 22, 2022) | ||
6-32976044-T-C | Uncertain significance (Nov 01, 2023) | |||
6-32976048-C-T | Likely benign (Jun 08, 2018) | |||
6-32976246-C-G | BRD2-related disorder | Benign (Dec 31, 2019) | ||
6-32976251-G-A | Likely benign (May 04, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRD2 | protein_coding | protein_coding | ENST00000395289 | 13 | 12846 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000433 | 125740 | 0 | 7 | 125747 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.593 | 417 | 453 | 0.922 | 0.0000251 | 5398 |
Missense in Polyphen | 92 | 139.23 | 0.66079 | 1640 | ||
Synonymous | -4.45 | 236 | 164 | 1.44 | 0.00000836 | 1682 |
Loss of Function | 5.05 | 3 | 35.5 | 0.0845 | 0.00000187 | 459 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000590 | 0.0000590 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000450 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in spermatogenesis or folliculogenesis (By similarity). Binds hyperacetylated chromatin and plays a role in the regulation of transcription, probably by chromatin remodeling. Regulates transcription of the CCND1 gene. Plays a role in nucleosome assembly. {ECO:0000250, ECO:0000269|PubMed:18406326}.;
- Pathway
- Chemical Compounds to monitor Proteins;Gene expression (Transcription);RUNX3 regulates p14-ARF;Transcriptional regulation by RUNX3;Generic Transcription Pathway;RNA Polymerase II Transcription;Regulation of retinoblastoma protein
(Consensus)
Recessive Scores
- pRec
- 0.542
Intolerance Scores
- loftool
- 0.201
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.25
Haploinsufficiency Scores
- pHI
- 0.412
- hipred
- N
- hipred_score
- 0.423
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brd2
- Phenotype
- craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype;
Zebrafish Information Network
- Gene name
- brd2a
- Affected structure
- thrombocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- nucleosome assembly;regulation of transcription by RNA polymerase II;spermatogenesis;viral process
- Cellular component
- nucleoplasm;cytoplasm;nuclear speck
- Molecular function
- chromatin binding;protein binding;lysine-acetylated histone binding